Knowledge hub

News

News

Resounding Success of OncoActive Days 2023 

New Paper Released by Ardigen and Collaborators: Advances in AI – Powered Histological Evaluation of Crohn’s Disease and Ulcerative Colitis
Code Against Cancer’s “ONCOdecalogue of Emotions” Receives Acclaim at PTPO Conference
Ardigen Celebrates 8 Years of Innovation in AI Drug Discovery
Ardigen Teams Join Forces at the 12th “Poland Business Run”
Ardigen Collaborates on Breakthrough in TCR Therapy Advancements
Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska
Ardigen Representatives Share Expertise with Silesian University of Technology Students
Leave Your Trace Foundation and Ardigen Unveil “ONCODecalogue of Emotions” for Children Facing Health Challenges
News

Hackathon – March 2023

Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Ardigen at SLAS International Conference & Exhibition 2023
Meet Ardigen phenAID platform
Ardigen at PMWC 2023
Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board
Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board